All Viruses articles – Page 10
-
NewsPlant viruses open new routes for gene editing
A new study has developed potyvirus-derived vectors for delivering CRISPR RNA (crRNA) guides in Lachnospiraceae bacterium ND2006 Cas12a (LbCas12a)-expressing plants, expanding virus-induced gene editing from tobacco rattle virus (TRV) to tobacco etch virus (TEV), turnip mosaic virus (TuMV), and lettuce mosaic virus (LMV).
-
NewsWastewater analysis offers a new way to monitor HIV in communities
Human immunodeficiency virus 1 (HIV-1) detection in wastewater offers a novel approach to monitor the virus in communities. Hybrid-capture genetic sequencing allows researchers to analyze viral genomes in detail and specifically identify viral signals coming from community wastewater.
-
NewsShingles vaccine linked to lower dementia risk in older adults, study suggests
A target trial emulation of older adults entering skilled-nursing facilities found that those who received the recombinant shingles vaccine (RZV) had a lower risk of developing dementia over the following four years compared with those who were not vaccinated.
-
NewsmRNA flu vaccine offers immune protection against wide array of influenza virus strains
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
-
NewsMetformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long Covid by 50%
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
-
NewsScientists track breakthrough single-dose vaccines for Andes hantavirus strain
Researchers report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus after a single dose. They are working to fast-track these single-dose vaccines into human clinical trials.
-
NewsElsevier launches Ebola Information Center with free clinical and research resources
Elsevier has launched an Ebola Information Center to provide healthcare professionals, researchers, policy makers and the public with free access to critical clinical and research information to support the global response to this outbreak.
-
NewsMolecular anchors on gut phages may open new avenues for therapeutic development
A new study has identified phage surface proteins acting as molecular anchors. These proteins confer phages with the ability to attach to human cells. Using genetic engineering, the researchers transferred these adhesion proteins onto the surface of another phage that otherwise lacked this ability.
-
NewsExploring potential of virovory in combating harmful algal blooms
Toxic cyanobacterial blooms can close lakes, contaminate drinking water and pose risks to human health. A new project is exploring an unlikely tool for mitigating these blooms: virovory, the phenomenon of organisms eating viruses as a food source.
-
NewsGenomic analysis redefines the origin of eukaryotic cells
A new genetics study using the MareNostrum supercomputer redefines the genetic origin of the last common ancestor of all eukaryotes, highlighting the contribution of novel bacteria and even giant viruses in the emergence of eukaryotic cells.
-
NewsAsk the expert: World Cup travel and Ebola risk
Luis Ostrosky, MD, division chief of infectious diseases at McGovern Medical School at UTHealth Houston and chief epidemiology officer for Memorial Hermann Health System addresses the Ebola outbreak in Congo and Uganda and how the United States could be affected through travel.
-
NewsAs California warms, cases of dengue fever are expected to grow
Historically, dengue fever has been rare in California. But according to new research, a warming climate is making parts of the state more hospitable to the illness — and the mosquitoes that carry it.
-
NewsScientists probe antiviral molecules in bacteria that target bacteriophages
Researchers have examined the antiviral molecule daunorubicin, produced by Streptomycetes, and decoded its mode of operation against viruses. They now describe this mechanism, which primarily targets a specific group of viruses – namely bacteriophages.
-
NewsBacteria organise themselves into diverse, coordinated communities in order to travel across large distances
A new study examined the migration of microbial communities over long distances, and found bacteria migrate not as solitary swimmers, but in diverse, coordinated communities that also contain viruses and “hitchhiking” microbes that cannot swim on their own.
-
NewsFirst-in-human clinical trial shows promising results for new Lassa fever vaccine
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
-
NewsPlants could be used to grow medicines in space, study shows
Astronauts on long space missions may one day use plants to produce fresh stocks of medicines on demand. Researchers developed a simple method to grow and repeatedly harvest plant virus-based pharmaceuticals from plants under space-like conditions, without destroying the plants or generating large amounts of waste.
-
NewsTesting AI against public health’s existing tools
A new study found that AI chatbots made vaccine-hesitant parents more likely to say they would vaccinate their children against HPV, but did not outperform materials from government health agencies, whose effects also lasted longer.
-
NewsAccelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.
-
NewsNew study highlights maternal-fetal TORCH infection risk
Researchers have assessed long-term trends in TORCH infections in India, a region where reliable data have been lacking. TORCH includes pathogens that cause toxoplasmosis, rubella, cytomegalovirus (CMV), herpes simplex virus and other infections.
-
NewsNew tool quickly sequences hantavirus genome
The genetic diversity of hantavirus and the low levels of virus typically found in patient samples make sequencing its genome particularly challenging. Researchers have developed a new, effective, and low-cost way to carry out whole genome sequencing for hantaviruses.